Current biotech euphoria is driven by fundamentals and M&A appetite, says Jonathan Faison, who runs ROTY Biotech Communi

Must Reads

 

Top Stocks H2 2026: Subscribe to Premium to join the event. Register now »

 
 
 

FREE TRENDING ARTICLE

Biotech Euphoria Driven By Fundamentals 

Current biotech euphoria is driven by fundamentals and M&A appetite, says Jonathan Faison, who runs ROTY Biotech Community. Focusing on high-convictio...

Read For Free
 
 
 

FEATURED

Join our Top Stocks event on July 14

Steven Cress will present Seeking Alpha’s Top 10 Stock Picks for H2 2026. Subscribe to Premium for $4.95 for your first month and gain actionable insights for the months ahead.

Register Now
 
 
 

Buy The Dip And Ride The Rotation: 5 Top Growth And Income Stocks 

I identify five growth and income stocks across diverse industries, helping investors navigate today's volatile market with greater confidence. These ...

Continue Reading
 
 
 

Palantir: Implications Of 90x P/E 

Palantir Technologies Inc. is positioned for long-term growth, driven by catalysts unveiled at AIPCon 10. PLTR’s recent share price correction, when c...

Continue Reading
 
 
 

Tesla: Why A Big Earnings Beat Is Likely 

Tesla, Inc. remains my top long-term holding, driven by dominant Q2 deliveries and a robust multi-segment ecosystem. Q2 deliveries hit a record 480,12...

Continue Reading